文献速递关节外科运动医学

孤立性外侧胫股间室骨关节炎:外侧固定平台单髁膝关节置换术后平均10年随访的生存率与患者可接受症状状态

Isolated Lateral Tibiofemoral Compartment Osteoarthritis: Survivorship and Patient Acceptable Symptom State After Lateral Fixed-Bearing Unicompartmental Knee Arthroplasty at Mean 10-Year Follow-up.
PubMed 文献 · J Bone Joint Surg Am · 2022-06-28

本研究纳入61例接受非机器人辅助外侧固定平台单髁膝关节置换术的孤立性外侧间室骨关节炎患者,平均随访10年。年轻/中年组与老年组所有患者报告结局无显著差异,假体平均生存估计15.3年,两组PASS达成率均较高。作者认为该术式长期生存率高、PASS达成率高且并发症和失败风险低。

要点

  • 外侧固定平台非机器人单髁置换术后平均随访10年,假体平均生存估计15.3年(95%CI 14.5至16.2年)。
  • 年轻/中年组(<60岁)假体生存率5年和10年均为100%,老年组(≥60岁)5年98%、10年96%。
  • KOOS ADL和Sport子量表PASS达成率年轻组分别为82%和88%,老年组均为80%和80%。

核心结论

  • 外侧固定平台非机器人单髁膝关节置换术治疗孤立性外侧间室骨关节炎,使超过80%的患者在日常生活活动和体育活动方面达到可接受症状状态。
  • 作者认为该术式提供了长期生存率、高PASS达成率和恢复活动能力,且并发症和失败风险低。

研究设计与样本

  • 所有患者由单一术者采用外侧髌旁入路行非机器人辅助固定平台外侧单髁膝关节置换术。
  • 共256例患者接受内侧(n=193)或外侧(n=63)单髁置换,其中61例符合纳入标准。
  • 患者分为2组:年轻/中年组(<60岁)和老年组(≥60岁)。
  • 失败定义为转为全膝关节置换术。
  • 证据等级为治疗性III级。

主要发现

  • 平均随访10年(范围4至17年)时,两组在任何患者报告结局指标上均无显著差异(p>0.05)。
  • KOOS ADL和Sport子量表PASS达成率在年轻组分别为82%和88%,在老年组分别为80%和80%。
  • 整个队列假体平均生存估计为15.3年(95%CI 14.5至16.2年)。
  • 年轻组假体生存率在5年和10年均为100%;老年组5年生存率为98%,10年为96%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lateral unicompartmental knee arthroplasty (UKA) is an excellent option to alleviate disability and restore function in patients with lateral compartment knee osteoarthritis (OA). The purpose of the present study was to determine the survivorship and long-term outcomes in both younger/middle-aged and older patients with lateral compartment OA following non-robotically-assisted, fixed-bearing lateral UKA and to determine if an acceptable symptom state can be achieved. METHODS: All patients were managed with fixed-bearing lateral UKA by a single surgeon utilizing a lateral parapatellar approach without robotic assistance. The primary outcome variables were the Knee injury and Osteoarthritis Outcome Score (KOOS) Activities of Daily Living (ADL) and Sport subscale scores. In addition, the other KOOS subscores, the Lysholm score, the achievement of the Patient Acceptable Symptom State (PASS), and the Veterans RAND (VR-12) Physical Component Summary score (PCS) and Mental Component Summary score (MCS) were collected. Failure was defined as conversion to total knee arthroplasty (TKA). Patients were divided into 2 cohorts: younger/middle-aged patients (<60 years of age) and older patients (≥60 years of age). RESULTS: A cohort of 256 patients underwent medial (n = 193) or lateral (n = 63) UKA. Sixty-one patients met the inclusion criteria. At mean of 10 years (range, 4 to 17 years) of follow-up, there were no significant differences between the groups in terms of any patient-reported outcome measures (p > 0.05). The percentage of patients in whom PASS was achieved on the KOOS ADL and Sport subscores was 82% and 88%, respectively, in the younger cohort and 80% and 80%, respectively, in the older cohort. The mean survival estimate of the prothesis was 15.3 years (95% confidence interval [CI], 14.5 to 16.2 years) for the entire cohort. The estimated rate of implant survival in the younger cohort was 100% at 5 and 10 years, and the estimated rate of implant survival in the older cohort was 98% at 5 years and 96% at 10 years. CONCLUSIONS: Lateral fixed-bearing, non-robotic UKA for the treatment of isolated lateral compartment OA resulted in >80% of patients reaching an acceptable symptom state in terms of both activities of daily living and sporting activities. UKA provides an excellent option that provides longevity with high PASS rates and return to activities with a low risk of complications and failure. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Plancher KD, Briggs KK, Chinnakkannu K, et al. Isolated Lateral Tibiofemoral Compartment Osteoarthritis: Survivorship and Patient Acceptable Symptom State After Lateral Fixed-Bearing Unicompartmental Knee Arthroplasty at Mean 10-Year Follow-up. J Bone Joint Surg Am. 2022. PMID: 35766399. doi:10.2106/JBJS.21.01523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。